A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 ce...
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team
About this item
Full title
Author / Creator
Hammer, S M , Katzenstein, D A , Hughes, M D , Gundacker, H , Schooley, R T , Haubrich, R H , Henry, W K , Lederman, M M , Phair, J P , Niu, M , Hirsch, M S and Merigan, T C
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
This double-blind study evaluated treatment with either a single nucleoside or two nucleosides in adults infected with human immunodeficiency virus type 1 (HIV-1) whose CD4 cell counts were from 200 to 500 per cubic millimeter.
We randomly assigned 2467 HIV-1--infected patients (43 percent without prior antiretroviral treatment) to one of four d...
Alternative Titles
Full title
A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_8813038
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_8813038
Other Identifiers
ISSN
0028-4793
